Open Access

COVID-19 Pandemic and Cardiovascular Challenges


Cite

1. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. doi: 10.1001/jama.2020.4683. [Epub ahead of print]10.1001/jama.2020.4683Search in Google Scholar

2. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;pii:ehaa231. doi: 10.1093/eurheartj/ehaa231. [Epub ahead of print]10.1093/eurheartj/ehaa231Search in Google Scholar

3. Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;pii:ehaa235. doi: 10.1093/eurheartj/ehaa235. [Epub ahead of print]10.1093/eurheartj/ehaa235Search in Google Scholar

4. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovascular Research. 2020;cvaa078. doi: 10.1093/cvr/cvaa078.10.1093/cvr/cvaa078Search in Google Scholar

eISSN:
2457-5518
Language:
English